rxfast.net Quick Pharmacy Navigator

Tag: Paragraph IV certification

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
Pharmacy

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

  • Gareth Wycliffe
  • Dec 10, 2025

The first generic drug filer gets 180 days of exclusive market rights under the Hatch-Waxman Act. This rule was meant to lower drug prices-but loopholes let companies delay competition. Here’s how it works, who benefits, and why reform is overdue.

Recent Posts
  • How to Read OTC Drug Facts Labels Correctly and Confidently Mar 21, 2026
  • Pediatric Hearing Loss: Screening, Causes, and Early Intervention Dec 1, 2025
  • Pim-800 (Paracetamol) vs Common Pain Relievers: Detailed Comparison Oct 8, 2025
  • Medication Therapy Management (MTM) Explained: A Patient’s Guide to Better Care May 7, 2026
  • Adverse Event Reporting: What Pharmacists Must Do for Generic Medication Safety Dec 2, 2025
Categories
  • Health (86)
  • Pharmacy (80)
  • Medications (63)
  • Supplements (3)
  • Investments (1)
Tag Clouds
  • online pharmacy
  • medication safety
  • generic drugs
  • drug interactions
  • medication adherence
  • online pharmacy safety
  • generic medications
  • Hatch-Waxman Act
  • therapeutic equivalence
  • GoodRx coupons
  • medication side effects
  • 180-day exclusivity
  • DOACs
  • blood thinners
  • bioequivalence
  • fertility
  • erectile dysfunction
  • medication
  • inflammation
  • hair loss treatment
  • About RXFast.net
  • Terms & Conditions
  • Privacy Policy
  • GDPR Compliance Framework
  • Contact Us

©2026 rxfast.net. All rights reserved